In a patient with knee pain and a diagnosis of psoriasis, should I check his serum 25‑hydroxyvitamin D level and treat any deficiency with vitamin D supplementation?

Should You Check Vitamin D Levels and Supplement in This Patient with Psoriasis and Knee Pain?

Yes, check serum 25-hydroxyvitamin D levels and treat any deficiency found, targeting a level of at least 30 ng/mL, though this is primarily for bone health and fall prevention rather than psoriasis treatment itself.

Rationale for Vitamin D Testing

The Endocrine Society guidelines 1 recommend measuring serum 25(OH)D levels in patients at risk for deficiency, and serum 25(OH)D is the best indicator of vitamin D status 2. For patients with musculoskeletal complaints like knee pain, vitamin D deficiency can contribute to bone health issues, muscle weakness, and increased fall risk 1.

Target Levels and Treatment Strategy

• Target serum 25(OH)D: ≥30 ng/mL 1, 3, 1
• If deficient (<30 ng/mL), treat with 50,000 IU vitamin D2 or D3 weekly for 8 weeks 1
• Alternative: 6,000 IU daily for the same period 1
• Recheck levels after 3 months of supplementation 3, 4
• Maintenance therapy: 1,500-2,000 IU daily after correction 1

The Psoriasis Connection: Important Caveats

While you should check and treat vitamin D deficiency in this patient, understand that oral vitamin D supplementation does not effectively treat psoriasis itself 5, 6, 7.

What the Evidence Shows:

Observational data: Psoriasis patients consistently have lower 25(OH)D levels than controls (21.0 vs 27.3 ng/mL, p<0.00001) 6, with an inverse correlation between vitamin D levels and disease severity 8, 9, 10.

Clinical trial data: Multiple RCTs show no significant improvement in PASI scores with oral vitamin D supplementation 6, 7. A 2018 RCT using 100,000 IU monthly found no differences in PASI, Physician Global Assessment, or quality of life measures after 12 months 7. The 2023 meta-analysis confirmed no PASI improvement at 3,6, or 12 months 6.

Topical vitamin D works differently: Topical vitamin D analogs (calcipotriene, calcitriol) are effective first-line treatments for psoriasis 11, 5, but this represents a local pharmacologic effect, not correction of systemic deficiency.

Clinical Algorithm

1. Order serum 25(OH)D level (not 1,25-dihydroxyvitamin D) 2, 3

2. If <30 ng/mL:

   • Start 50,000 IU vitamin D2 or D3 weekly × 8 weeks 1
   • Recheck level in 3 months 3, 4
   • Transition to maintenance 1,500-2,000 IU daily 1

3. If 20-30 ng/mL (mild deficiency):

   • Alternative: Add 1,000 IU daily and recheck in 3 months 2

4. For psoriasis treatment:

   • Use topical vitamin D analogs (calcipotriene/calcitriol) 11, 5
   • Do NOT rely on oral supplementation for psoriasis control 5, 6, 7

Special Considerations

Obesity: If the patient is obese, they may need 2-3 times higher doses (6,000-10,000 IU daily) to achieve target levels 1. The combination of high BMI and vitamin D deficiency (<25 ng/mL) shows a superadditive effect on active psoriasis risk (OR 1.92) 12.

Monitoring: No need to routinely check PTH, calcium, or other indirect markers 3. However, if treating with high doses, consider monitoring calcium to avoid hypercalcemia, which becomes a risk when 25(OH)D exceeds 100 ng/mL 2, 3.

Seasonal timing: Ideally measure at end of winter when levels are lowest 3, though this shouldn't delay testing if clinically indicated.

Bottom Line

Check the vitamin D level for bone health and fall prevention benefits, not for psoriasis treatment. Correct any deficiency found using standard repletion protocols. For the psoriasis itself, focus on topical vitamin D analogs combined with other evidence-based therapies rather than expecting oral supplementation to improve skin disease 11, 5, 6, 7.